Status:
COMPLETED
A Clinical Study of Enlicitide and the Effect of Food in Healthy Adult Participants (MK-0616-033)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The goal of the study is to learn what happens to enlicitide decanoate in a healthy person's body over time when taken on an empty stomach or with food. Researchers will compare what happens to enlici...
Eligibility Criteria
Inclusion
- The main inclusion criteria include but are not limited to the following:
- \- Has body mass index (BMI) ≥18 kg/m\^2 and ≤32 kg/m\^2
Exclusion
- The main exclusion criteria include but are not limited to the following:
- History of gastrointestinal disease which may affect food and drug absorption, or has had a gastric bypass or similar surgery
- History of cancer (malignancy)
- Positive test(s) for Hepatitis B surface antigen (HBsAg), hepatitis C antibodies or Human immunodeficiency virus (HIV)
- History of a major surgery
- Is lactose intolerant
Key Trial Info
Start Date :
October 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06609512
Start Date
October 21 2024
End Date
January 31 2025
Last Update
February 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Celerion ( Site 0001)
Tempe, Arizona, United States, 85283